文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

美国院内心脏骤停与院外心脏骤停体外生命支持应用与结局的国家趋势

National trends in utilization and outcomes of extracorporeal support for in- and out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2020-03-17
一句话结论2005至2014年美国心脏骤停患者ECLS使用率大幅上升,接受ECLS者出院生存率OHCA从34.2%升至54.2%、IHCA从4.7%升至19.2%。

该研究利用美国全国住院患者样本(National Inpatient Sample)分析2005至2014年院外心脏骤停(OHCA)及院内心脏骤停(IHCA)患者,排除妊娠、放弃复苏医嘱及创伤相关诊断者,共识别约1,624,827例患者。研究期间ECLS使用率在OHCA中从每10万例骤停77例增至564例,在IHCA中从60例增至632例。接受ECLS的OHCA患者生存率从34.2%升至54.2%,IHCA患者从4.7%升至19.2%。年龄、骤停年份、心律及存在可逆病因(包括心肌梗死和肺栓塞)可预测ECLS使用;在ECLS患者中,年龄、骤停心律及骤停地点可预测出院生存。作者认为随着ECLS使用增加,制定筛选标准以最大化获益至关重要。

要点

  • 2005至2014年ECLS使用率OHCA从每10万例骤停77例升至564例,IHCA从60例升至632例。
  • 接受ECLS者出院生存率OHCA从34.2%升至54.2%,IHCA从4.7%升至19.2%。
  • 年龄、骤停年份、心律及存在可逆病因(包括心肌梗死和肺栓塞)可预测ECLS使用。
  • 在ECLS患者中,年龄、骤停心律及骤停地点可预测出院生存。
  • 作者认为随着ECLS使用增加,制定筛选标准以最大化ECLS获益至关重要。

适用人群与场景

  • 2005至2014年美国全国住院患者样本中院外心脏骤停后入院及院内心脏骤停的患者。
  • 排除妊娠患者、有放弃复苏医嘱者及创伤相关诊断者。

研究设计与关键结果

  • 研究类型为基于美国全国住院患者样本的分析,共识别约1,624,827例患者。
  • ECLS使用率OHCA从每10万例骤停77例增至564例,IHCA从60例增至632例。
  • 接受ECLS的OHCA患者出院生存率从34.2%升至54.2%,IHCA患者从4.7%升至19.2%。
  • 年龄、骤停年份、心律及存在可逆病因(包括心肌梗死和肺栓塞)可预测ECLS使用。
  • 在ECLS患者中,年龄、骤停心律及骤停地点可预测出院生存。

证据类型、等级与局限

  • 证据类型:基于全国住院患者样本的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为随着ECLS使用增加,制定筛选标准以最大化ECLS获益至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Extracorporeal life support (ECLS) has shown promise in the management of cardiac arrest. The purpose of this study was to examine temporal trends and predictors of ECLS utilization and survival to discharge among inpatients with cardiac arrest in the United States.

METHODS: All patients admitted after out-of-hospital cardiac arrest (OHCA) and those who experienced in-hospital cardiac arrest (IHCA) from 2005 to 2014 were identified in the National Inpatient Sample. Patients carrying a pregnancy as well as those with do-not-resuscitate orders or trauma-related diagnoses were excluded. Multivariable logistic regression was used to identify predictors of ECLS utilization and survival to discharge.

RESULTS: An estimated 1,624,827 patients were identified. During the study period, use of ECLS increased from 77 to 564 per 100,000 arrests for OHCA, and 60 to 632 per 100,000 arrests for IHCA. Survival among patients on ECLS for OHCA and IHCA increased from 34.2% to 54.2% and from 4.7% to 19.2%, respectively. Age, year of arrest, cardiac rhythm, and the presence of a potentially reversible etiology including myocardial infarction and pulmonary embolism, were predictive of ECLS utilization. Among patients placed on ECLS, age, rhythm at arrest, and location of arrest were predictive of survival to discharge.

CONCLUSIONS: Mortality after cardiac arrest for those on ECLS has substantially decreased. Younger age, shockable rhythm, and out-of-hospital arrest location were predictive of survival or utilization. As ECLS use increases, it is critical to define selection criteria that maximize the benefits of ECLS.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Hadaya J, Dobaria V, Aguayo E, et al. National trends in utilization and outcomes of extracorporeal support for in- and out-of-hospital cardiac arrest. Resuscitation. 2020. PMID: 32194166. doi:10.1016/j.resuscitation.2020.02.034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。